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Purpose. The PJTX3 gene, which codes for a homeobox bi- 
coidlike transcription factor is responsible for dominant cata­
ract and anterior segment mesenchymal dysgenesis in humans. 
In the current study, a family with autosomal dominant poste­
rior polar cataract (FFC) and a PJTX3 mutation that cosegre- 
gates with the disease was examined. Also studied w ere two 
siblings w ho w ere homozygous for the PJTX3 mutation who 
had microphthalmia and significant neurologic impairment.
Methods. A genome-wide screen, linkage analysis in the I ' f lX J  
chromosomal region 10q25, haplotype analysis, and sequenc­
ing of the PJTX3 gene w ere performed on 28 affected and 14 
unaffected member of a three-generation Lebanese family. 
Results. C.enome-wide linkage analysis showed a lod score of 
3.56 at 8 = 0.00 on chromosome 10 at area q25. Analysis of the 
haplotypes and phenotypes confined the disease locus to a 
region on 10q25 between the markers D 10S1239  and 
D 10S1268. A candidate gene, PJTX3, maps to that region. 
Sequencing of the PJTX3 gene revealed a heterozygous C. 
deletion mutation in 25 of the 42 family members. In addition, 
two siblings from a consanguineous marriage w ere found to be 
homozygous for the deletion.
Conclusions. This is the first report of homozygous PJTX3 
mutations in humans. The phenotype in these individuals high­
lights the role of PJTX3 in ocular and central nervous system 
(CNS) development. (In v e s t O ph tha lm ol Vis Sci. 2006;47: 
1274-1280) 1)01:10.1 l67/iovs.05-1095
ongcnital cataracts occur in 30 of each 100,000 births in
developed countries. They are most commonly inherited 
as autosomal dominant traits and have a variety7 of phenotypic
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presentations.1,2 Autosomal dominant congenital cataract 
(Al)CC) is heterogeneous and has been assigned to a wide set 
of genes, including some that are responsible for the early 
development of the anterior segment of the eye, as well as 
others involved in the maturation of the lens.1 Among these 
genes, mutations in PJTX3 (Mendelian Inheritance in Man 
[M1MJ 602669; National Center for Biotechnology7 Information 
[NCB1J, Bethesda, Ml)), a transcription factor containing a 
homeodomain (111)), have been demonstrated to cause cata­
racts and anterior segment mesenchymal dysgenesis (ASM!)) in 
several families of distinct ethnic origins.? J Three mutations 
have been reported in human PJTX3: a C.-to-A substitution in 
the N-terminal region, 38C.^>A(S13N)J; a deletion of a single 
nucleotide (650delC.)?; and a 17-bp insertion (656ins17, de­
scribed elsewhere as 657-673dupl7),?-J the last two affecting 
the C-terminal portion of the protein. Also, two deletions have 
been described in the mouse, one of 652 bp in the 5' untrans­
lated region (UTR) and the other of 1423 bp in the proximal 
prom oter and exon 1 of P itx3 , in the homozygous aphakia (a k ) 
mouse in which they cause microphthalmia and arrest in lens 
development.5,0'
Pi 1x3 is expressed in the developing lens, skeletal muscle, 
and dopaminergic neurons of the substantia nigra in the brain.7 
Neurons in the substantia nigra are responsible for fine move­
ment control. It has recently been demonstrated that the a k  
mouse also has an abnormal profile in the output of some 
spatial movements.s To date, there have been no reports of 
humans homozygous or com pound heterozygous for PJTX3 
mutations.
Here w e report a three-generation Lebanese family with 
posterior polar cataract (FFC) in 28 affected individuals and a 
mutation in PJTX3 (650delC.) that cosegregates with the dis­
ease. In addition, two brothers from a consanguineous mating 
w ere found to be homozygous for the deletion and showed a 
more severe ocular and neurologic phenotype, with severe 
microphthalmia and neurologic deficits. This is the first report 
of human homozygosity for a mutation in PJTX3 and the first 
evidence of the involvement of this gene in human neurologic 
development.
M eth o d s
S ub jec ts
Forty-two members of a PPC family have been enrolled in a genetic 
research program through the Universit e St. Joseph Hotel-Dieu de 
France (Beirut. Lebanon). The ophthalmic Information for each indi­
vidual was scored as affected or unaffected by two of the authors (FIT. 
AK). both ophthalmologists. The Information on each patient was 
obtained from medical records when available, or from personal ex­
amination. Some of the examinations were limited and were per­
formed during a field trip to the remote village where many members 
of this family resided. By history and by review of the medical records, 
all study subjects had had clinically suspected cataract since birth or
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shortly thereafter. Twenty-eight, affected and 14 unaffected family 
members were examined and enrolled in the study. Other recognized 
systemic associations or combinations of infantile cataract were ex­
cluded whenever possible. Each subject, or the responsible adult on 
behalf of minors, signed a consent form for participation in these 
investigations, which was approved by the Review Board for Human 
Subject Research at the Cleveland Clinic Foundation and the parallel 
committees at the Universit. c St. Joseph Hotcl-Dieu de France. The 
study research followed the tenets of the Declaration of Helsinki.
M ark e rs  a n d  G e n o ty p in g
Genotyplng was performed (PRISM Linkage Mapping Set ver. 2.5. 
MD10: Applied Biosystems. Inc. |ABI|. Foster City. CA) for the whole 
genome according to the manufacturer's recommendations. Selected 
markers were chosen from chromosome 10. area q25. according to the 
Ensembl Genome Browser (litt.p://www.ensembl.org9) and their 
chromosomal positions were confirmed on the sequence of the 
SuperContig NTJX30059 (accession number ENSG00000107859). 
Marker information and primers were obtained from UniSTS (http:// 
www.ncbi.nlm.nih.gov/ent.rez/query.fcgi?db=unist.s/ provided in the 
public domain the National Center for Biotechnology Information. 
Bethesda. MD). We designed a new polymorphic marker. C.hl0cal2. 
positioned between markers D10S1266 and D10S1265. The primers 
for C.hlOca!2  are: forward 5'-CACAGAGACACAGGCAAAGGC-3': re­
verse 5 '-GCTGTGTGTACGCATCTCTGTTTTG-3'. The observed PCR 
product size range was 113 to 129 bp. The amplification reactions 
were performed in a thermal cycler (GeneAmp PCR system 9700: 
Perkin Elmer. Wellesley. MA). The amplified products were visualized 
on a sequencer (3100 Sequencer: ABI) according to the manufacturer's 
recommendations. The data were analyzed on computer (Genotyper 
3.7: ABI). The Mendelian inheritance was confirmed with PedCheck 
ver. 1.1 software (http://watson.hgen.pitt.edu/rcgister/docs/pcdchcck. 
html/ developed by Jeff O'Connell. University of Pittsburgh. Pitts­
burgh. PA).
L in k ag e  A n a lysis
Linkage analysis wras performed on the genome-wide genotype data 
and identified a positive lod score* of 3.56 (0 = 0.00) to the marker 
D10S2470 on chromosome 10q25. This region wras investigated wTit.h 
a more detailed analysis. The genotypes from 22 published and custom- 
designed markers in the critical region wrerc analyzed wTit.h conven­
tional parametric twTo-point. linkage analysis using the FASTLINK pro­
gram suite (http://softlib.cs.ricc.edu/ provided in the public domain by 
Rice University. Houston. TX). A dominant model of inheritance wTit.h 
90% penetrance in both heterozygous and homozygous individuals wras 
used wTit.h a disease allele frequency of 0.001. followed by multipoint 
analysis using Allegro.10 To accomplish this wTit.h Allegro's constraints 
on family size, the large pedigree wras broken dowrn into seven sub­
pedigrees. Tabular and graphic two-point, and multipoint, linkage data 
wTere inspected to establish the most, likely region wTit.h the gene.
M u ta tio n  A n a lysis
PCR primers wTere designed to amplify and sequence the exons and 
intron-exon junctions of all four coding exons of PITX3. according to 
GenBank (Tittp://www.ncbi.nIm.nih.gov/GenBank/ provided in the 
public domain by NCBI). Their sequences are in Table 1. Also. PCR 
primers wTere designed to amplify and to sequence a 1-kb region, 
including the 5'-LTTR upstream of the exon 1 translation start, site and 
the 3'-UTR of exon 4. Their sequences are in Table 1. All amplification 
reactions wTere performed wTit.h standard PCR conditions in the thermal 
cycler (GeneAmp PCR system 9700: Perkin Elmer). The amplified 
products wTere purified (QLVquick PCR Purification Kit.: Qiagen. Valen­
cia. CA) and sequenced (BigDye Terminator Cycle Sequencing Ready 
Reaction: DNA sequencing kit.: ABI) in the fonvard and reverse direc­
tions. according to the manufacturer s recommendations. Sequencing 
results wTere visualized (3100 Sequencer: ABI). according to the man-
T ab i.e  1 . Primers for PITX3
Prim er Sequence
Exon 1-F 5' - CCCTGGTCTGCCATAAAGTG- 3'
Exon 1-R 5' - TTTAGGGATTCCAAGGTCCA- 3'
Exon 2-F 5' - GGCTGGGGTTGAGAAAGGCG- 3'
Exon 2-R 5' - CCACTCGCTGGCTCCCACC- 3'
Exon 3-F 5' - GCAGCCCCGGTGGGAGC- 3'
Exon 3-R 5' -GGGAGGGGGCAGGTGGG-3'
Exon 4-F 5' - CCGTCTCTAGCCACCTCATC- 3'
Exon 4-R 5' - CCAGTCAAAATGACCCCAGT- 3'
Upstream distal-F 5' -AAGTCAGAGAGGGCCGAAGT- 3'
Upstream distal-R 5' - CCAAGTGGGCGAGAGTAGAG- 3'
Upstream proximal-F 5' -ATCCACTTTCCTCGGGGTAG- 3'
Upstream proximal-R 5' -ACAGGCAGACTCCCAGTAGC- 3'
3'UTR-F 5' - CAACCTTAGTCCGTGCCAGT- 3'
3'UTR-R 5' - GAAGAGGACTCAAGCGCAAC- 3'
ufacturer s recommendations. The data wTere analyzed on computer 
(Sequencher ver. 3.1.1 sottware: Gene Codes. Ann Arbor. MI).
Amplified PITX3 exon 4 products wTere digested wTit.h the Still 
(New7 England BioLabs. Beverly. MA) restriction enzyme to test, for the 
650delG variant, allele. PCR products from the wTild-type samples do 
not. have a Still restriction site and remain undigested (793 bp). Dele­
tion of the guanine residue creates a Still restriction site, resulting in 
fragments of 456 and 337 bp. To ensure full digestion, samples wTere 
incubated overnight, at. 37°C. Undigested and digested products wTere 
analyzed on 3% agarose gels.
R esults
L in k ag e  A nalysis
A three-generation Lebanese family was screened for dominant 
PPC. The genome-wide genotyping and linkage analysis per­
formed in 21 affected family members indicated a significant 
positive lod score of 3.56 (6 = 0.00) with marker D 10S2470  on 
chromosome 10, region q25 (data not shown). Follow-up link­
age analysis with 28 affected and 14 unaffected family mem­
bers in the 10q25 region increased the lod score to 6.56 (6 = 
0.00) with marker D IG S1268  (Table 2).
H a p lo ty p e  A n a lysis
We performed haplotype analysis in the family w ith five infor­
mative polymorphic markers from the positive lod score region 
on 1 Oc|25. We found appropriate co-segregation of an “affected 
haplotype” (Fig. 1, shown in green) with the PPC phenotype in 
all family members except one, (2567), who had the affected 
haplotype but was phenotypically unaffected. We also found 
two recombinant individuals (2575 and 2581) in the interval of 
the five markers shown. The analysis of the haplotypes and 
phenotypes confines the locus to the region bounded by mark­
ers D 10S1239  and D 10S1268  (Fig. 1), which are the two 
markers with the highest lod scores in the linkage analysis.
PITX3 Mutation Analysis
Because PJTX3 maps between D 10S1239  and D IG S1268  and 
is responsible for ADCC and ASM1), the coding sequences of 
the gene w ere analyzed. A heterozygous G-deletion mutation at 
position 650 of exon 4 (Fig. 2) was found in 25 of the 42 
members of the family. The mutation was confirmed by restric­
tion enzyme digestion of P1TX3 exon 4 PCR products w ith 
Slid. The heterozygous samples with deleted sequences 
showed a digested profile of three bands, whereas the wild- 
type w ere not digested and the homozygous w ere fully di­
gested with only two bands (Fig. 3). The digestion profiles 
confirmed the sequence data for all individuals in the family
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T able  2 . T w o -P o in t. T.od S c o re  fo r  M a rk e rs  o n  1O q25
Lot! Score fo r 0
M arker
Location
(cM) .00 .01 .05 .10 .20 .30 .40
D W Sl667 100.92 -6.132 -3.944 -1.721 -0.737 0.109 0.342 0.252
DIOS 1777 101.76 -3.684 -1.902 0.118 0.859 1.243 1.053 0.555
DWS2475 103.43 -3.383 -1.593 0.386 1.084 1.407 1.166 0.621
DIOS 17 86 103.53 -5.146 -3.844 -1.330 -0.340 0.317 0.361 0.136
DWS1761 106.11 0.963 0.965 0.931 0.826 0.599 0.464 0.300
D10S1658 106.25 -3.627 -1.480 1.166 2.192 2.570 2.098 1.141
DWS579 109.33 0.609 0.598 0.549 0.493 0.408 0.319 0.181
D10S2470 112.58 -0.631 1.279 2.442 2.687 2.419 1.742 0.833
DIOS 536 114.73 -0.115 1.796 2.948 3.164 2.810 2.023 0.984
D10S200 117.42 -3.702 -0.877 1.107 1.769 1.952 1.524 0.743
DWS198 120.09 1.608 1.599 1.545 1.447 1.179 0.839 0.445
DIOS 60.3 120.37 1.533 2.780 3.768 3.966 3.550 2.620 1.339
DtOSt266 120.65 0.439 1.688 2.683 2.924 2.674 1.987 1.016
Ch 10Cat2 120.89 0.945 2.201 3.226 3.479 3.183 2.387 1.251
DI OS 1265 120.96 -0.037 0.863 1.594 1.825 1.747 1.337 0.728
DIOS 1710 121.07 1.100 1.075 0.964 0.824 0.549 0.302 0.106
DWS1239 121.81 6.567 6.502 6.169 5.673 4.473 3.022 1.359
DIOS 1268 122.82 6.568 6.533 6.305 5.902 4.806 3.384 1.662
DWS1760 128.19 -0.797 1.379 2.891 3.234 2.924 2.078 0.961
DIOS554 130.9 -4.261 -2.157 -0.061 0.728 1.165 1.010 0.559
DIOS 187 135.24 -3.803 -0.968 0.978 1.607 1.756 1.313 0.587
(data not shown). This mutation has been described in a 
Hispanic family with PPC (Addison PKF et al. lO VS  2004;45: 
ARVO B-Abstract 4749). The mutation cosegregates with the 
disease except for one nonpenetrant individual (num ber 2567) 
who carries the hetero7ygous deletion but has a normal phe­
notype (Figs. 1, 3). Two family members reported as affected 
(2553 and 2558) were found not to have the mutation. Al­
though the clinical reports indicated that these two people had 
the familial disease, they had had cataract extraction before 
examination by the authors, and so they possibly had some 
other form of cataract. Also, two siblings from a consanguine­
ous marriage (2594 and 2595) w ere found to be homo7ygous 
for the deletion (Figs. 2, 3).
C lin ica l F e a tu re s
Reduced vision and cataracts were reportedly present since 
birth in all patients in whom this information was available. No 
signs of anterior segment mesenchymal dysgenesis were ob­
served in any patient w ho had a slit lamp evaluation, and none 
had had glaucoma before or after the extraction of cataracts. 
The cataracts w ere of the posterior polar type and appeared as 
2- to 3-mm disks of dense whitish material in the center of the 
posterior lens capsule (for example, see Fig. 4). Some patients 
also had cortical and nuclear lens opacities of variable severity 
and density. Some had undergone cataract extraction early in 
life or in middle age, whereas others did not for a variety of 
social reasons and lack of access to care. Visual acuity was 
preserved, even in those w ho did not undergo cataract extrac­
tion. One such patient had a visual acuity of 20/60, despite the 
presence of a central dense posterior capsular opacity.
The severely affected siblings (2594 and 2595) had bilateral 
microphthalmia with corneal opacification and extremely poor 
vision. They had always been wheelchair bound and were 
severely developmentally delayed. They w ere 23 and 19 years 
of age, respectively, and were born to consanguineous parents. 
They had one developmentally normal 18-year-old sister w ith 
cataract and hetero7ygous deletion in /7/A. i. Both boys were 
born at term by normal vaginal delivery and had no neonatal 
distress.
Their ocular abnormalities and blindness w ere noted in the 
first 3 months of life, but significant physical disability became
apparent only by the age of 15 to 18 months when they failed 
to walk. They also had a significant delay in speech develop­
ment. By the age of 4 to 6 years they started having abnormal 
movements of their head and upper limbs and contractures in 
flexion of the knees. They acquired sphincter control at ap­
proximately age 10. Their encephalopathies w ere described as 
static, and they showed no signs of neurologic deterioration 
over the past two decades. On neurologic examination, they 
showed major disequilibrium w hen forced to stand upright. 
The knees w ere flexed with severe contractures of the ham­
string muscles. They could not understand orders of medium 
complexity. There w ere choreiform movements of the head 
and upper limbs and to a lesser extent, of the trunk. The upper 
body and limb tone was normal, but increased with contrac­
tures in the lower limbs. Reflexes w ere present but weak. 
There was no clear-cut response of plantar reflex (withdrawing 
of the foot, lack of cooperation). No sensory abnormalities 
w ere detectable, except blindness. Cerebellar functions were 
not assessable because of lack of cooperation. Vital signs were 
normal. Their clinical course had not shown any significant 
progressive deterioration over the past two decades, according 
to their parents. Some stereotypic behavior, such as eye-rub­
bing in the older brother and hitting of the face in the younger, 
was observed. The older brother had bilateral valgus deformi­
ties of the ankle joints. The younger brother was slightly less 
severely affected. Magnetic resonance imaging (MR1) of the 
brain in both brothers was normal except for the presence of 
optic nerve thinning and small globes.
D iscussion
Inherited PPCs are some of the least common types of congen­
ital cataracts. Three distinct P1TXJ mutations have been re­
ported to date that cause ADCC in families of different ethnic 
origins.5 ' 1” Most of these families w ere described to have 
PPC, defining the CPP4 locus.5 Anterior segment dysgenesis 
has also been associated with these m u ta tio n s '11 and has been 
attributed to interference with the normal function of PJTXJ in 
early anterior eye development. 12 The mutation w e found in 
the reported family cosegregates with the disease except for
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Figure 2. Deletion mutation in PITXJ (650delG). Forward (top) and 
reverse (bottom) sequencing chromatograms are shown for each ex­
ample. The G 650-base and the amino acid sequence and codon 
number are indicated in the wild-type panel. The amino acid changes 
are shown underscored in the homozygote panel. lateral arrows-. 
frameshift: vertical arrows: G deletion in the heterozygote and ho­
mozygote panels.
individual 2567, w ho appeared to be nonpenetrant for the FFC 
phenotype. Variable expressivity of the cataract and anterior 
segment dysgenesis phenotype has been observed in families 
with the P ITXJ  insertion mutation (656ins 17).11-15
FITX3 is a paired-like homeodomain transcription factor 
that belongs to the RIEG/FITX homeobox gene family.12 The 
650delG and the 656ins 17 mutations in P ITXJ  are close to  one 
another and affect the C-terminal region of the gene. The 
650delG mutation is 86-amino-acid residues upstream of the C 
terminus of the FITX3 protein. Although this region does not 
include the homeodomain, it is predicted that the resultant 
peptide lacks a 14-amino-acid motif identified within the C- 
terminal region of at least 40 paired class homeobox transcrip­
tion factors and named the OAR domain.11 Although the func­
tion of the domain is not well understood, mutations in the 
OAR domain of P itx2 , a gene associated w ith Rieger syndrome 
in humans, suggest a transactivation regulatory' role by inhib­
iting DNA binding and promoting interaction with other tran­
scription factors.15-1 Also, it was demonstrated for the Frxla 
homeoprotein, that the OAR domain inhibits transactivation,18 
and, in the Cartl homeoprotein, the domain serves as an 
intramolecular switch of its transactivation activity.19 How­
ever, RNA microinjection experiments with other bicoidclass 
homeobox genes like X r x i  (the X enopus  homologue to RA X) 
have demonstrated that the absence of the OAR domain can 
cause a passive repression of the downstream target genes.20
Because the human conditions described to date for PITXJ  
mutations are autosomal dominant, the phenotypes have been 
attributed to haploinsufticiency.1 Nevertheless, as deletion of 
the OAR domain leads to  transcriptional activation in P itx2 ,i5 
w e cannot rule out the possibility that the mutation described 
herein induces transactivation instead of downregulation of 
target genes. Also, w e cannot exclude the possibility that the 
mutation could result in a passive repression mechanism 
caused by the OAR-deleted FITX3 protein. Further experi­
ments are needed to  determine the specific role of the OAR 
domain in the function of FITX3.
The phenotype of the tw o siblings w ho w ere homozygous 
for the C-terminal deletion of FITX3 was much more severe 
than that of the heterozygous family members. In addition to 
having FFCs as in heterozygotes, the homozygous individuals 
had microphthalmia, blindness, and a neurologic disorder char­
acterized by mental retardation, choreiform movements, and 
increased muscle tone and decreased deep tendon reflexes of 
the lower extremities. Imaging studies of the two homozygous 
siblings did not reveal any gross abnormalities of brain devel­
opment; hence, it is likely that their neurologic syndrome is the 
result of cellular or interneuronal connection abnormalities. 
This phenotype, however, implies an essential role for PITXJ  
in normal ocular and CNS development.
Another paired box gene involved in eye and brain devel­
opment, P a xb , has been found in homozygous state to pro­
duce phenotypic ocular and extraocular defects. Small eye 
(Sey) mouse is a homozygous mutant of P axb  that lacks eyes, 
has craniofacial abnormalities, and dies soon after birth.21 Het­
erozygous mutations in P AX 6  have been described in humans 
with aniridia and other ocular anomalies such as cataract and 
Feters anomaly.1 Compound heterozygous P A X 6  mutations in 
humans have also been described with severe craniofacial and 
central CNS defects and no eyes.22 P A X 6  appears to  be a 
master control gene that synchronizes the events during the 
formation of the anterior eye and other central nervous struc­
tures.25 The target genes regulated by P ITXJ  are not yet estab­
lished, though it seems to  be an important key gene in the 
development of the eye and other tissues. Further studies are 
needed to  elucidate the molecular role of this transcription 
factor in early development.
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consanguineous family
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Figure 3. Stul restriction enzyme digestion of amplified PFTXJ exon 4 DNA for representative individ­
uals. For each sample, undigested, and digested DNA was loaded in the left and right lanes, respectively. 
A. affected; U. unaffected. The parents and siblings of the consanguineous family having two homozygote 
individuals are indicated. Filled circles-, phenocopies; open circles-, recombinants; asterisk-, nonpenetrant 
individual.
It was recently demonstrated in mice that P itx j  is ex­
pressed in the mesencephalic dopaminergic (DA) neurons that 
are located in the ventral midbrain and that form the substantia 
nigra compacta (SNc) and the ventral tegmental area.” The role 
of DA neurons is related to movement and behavior, and so 
they are a target for the understanding of the molecular mech­
anisms that underlie schizophrenia, addictive behavioral disor­
ders, and Parkinson's disease.7 Moreover, P itx j  defines the 
neuronal population required for spontaneous locomotor ac­
tivity, and is involved in the specification of properties of DA 
neurons during terminal differentiation and maintenance.21-25 
It has been demonstrated that the o k  mice have no P itx j  
expression in the SNc and that in the absence of P itx j ,  the DA 
neurons do not survive.26 Surprisingly, these mice have no 
motor defects, altered posture, waking pattern, or tremor, 
although they show aberrant behavior in a climbing test and 
lower overall motor activity levels.” Both homozygous brothers 
in this report showed severe disorders of motor function, 
including inability to walk, chorea, and diplegia with flexion 
contractures of the lower limbs, in accordance w ith the role of 
PJTX3 in movement skills and motor output capability, sug­
gesting a role for PJTX3, not only in anterior eye development 
and SNc differentiation and maintenance, but also in the CNS. 
In Parkinson's disease, there is a loss-of-function of adult SNc 
DA neurons, and the reason for this selective effect is un­
known.7 The two patients with homozygous deletion in PJTX3 
did not show classic symptoms of early Parkinson's disease, but 
their clinical picture maybe  compatible with advanced Parkin­
son's disease.
Figure 4. Retroilluminated view of pupillary space in an affected 
individual shows central posterior capsular round opacity (large ar­
row) and a few radial cortical opacities (small arrow).
The human ocular abnormalities found in the siblings with 
homozygous PJTX3 mutations resembled those of the o k  
mouse. It is conceivable that the severe neurologic phenotype 
in these siblings is due to homozygous or heterozygous muta­
tions at a locus unlinked to PJTX3- This however is unlikely, 
however, because the four consanguineous marriages in the 
family produced eight offspring. Of these, only two individuals 
had neurologic abnormalities, and these w ere the tw o individ­
uals w ho w ere homozygous for the PJTX3 mutation. It is still 
possible that a locus that is closely linked to PJTX3 is respon­
sible for the neurologic phenotype in a recessive model, since 
these two children w ere the only ones w ho had a homozygous 
genotype at that putative locus. Although this is impossible to 
investigate at this point, it is an unlikely possibility, given the 
suspected role of P1TX3 in brain development. Furthermore, 
the ocular and CNS phenotypes can be readily explained by the 
PJTX3 expression pattern, which supports the contention that 
the phenotype is caused by the PJTX3 mutation.
The neurologic phenotype of the two homozygous patients 
reveals a potential new  role of PJTX3 in the development of 
the nervous system that has not been described before in 
humans.
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